Analysed BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) News Sources
Wall Street Analysts Think BioCryst (BCRX) Could Surge 108.21%: Read This Before Placing a Bet
28-08-2026
yahoo.com
BioCryst’s Orladeyo Built The Cash Pile, CEO Gayer Wants To Buy The Next Asset
28-08-2026
stocktwits.com
Is BioCryst Pharmaceuticals (BCRX) Stock Outpacing Its Medical Peers This Year?
31-08-2026
yahoo.com
CareMed Has Been Selected as a National Pharmacy Partner by BioCryst and Adds Orladeyo® (berotralstat) to Growing Rare Disease Portfolio
08-09-2026
yahoo.com
BCRX Stock Posts Worst Day In Over 6 Months After PHVS Trial Win In Rare Swelling Disease
08-09-2026
stocktwits.com
BioCryst Pharmaceuticals Faces Competitive Pressure in Hereditary Angioedema Treatment, RBC Says
10-09-2026
yahoo.com
BCRX Stock Heads For Fifth Straight Day In The Red – RBC Capital Says BioCryst Faces A ‘Challenging Near-Term Outlook’
10-09-2026
stocktwits.com
What is the current price of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The current price of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is $8.16.
BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) since the previous trading day is $-0.07.
BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) since the previous trading day is -0.8505%.
What is the most recent average sentiment score for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The most recent average sentiment score for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is 61 out of 100.
What is the most recent average sentiment for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The most recent sentiment for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is .
SEC-8K** Filing Available For BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.